LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
暂无分享,去创建一个
J. Ji | Lianhai Zhang | Xiaofang Xing | X. Wen | ZhiXue Zheng | Xiaojiang Wu | Z. Bu | Shen Li | H. Du | Ying Hu | Xiao-hong Wang | Lin Li | R. Zhou | X. Cheng | Xiaojing Cheng
[1] Wei Zhang,et al. The incidences and mortalities of major cancers in China, 2010 , 2014, Chinese journal of cancer.
[2] Xiaojun Zhu,et al. Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos , 2013, Cell Research.
[3] Wanqing Chen,et al. The incidence and mortality of major cancers in China, 2012 , 2013, Chinese journal of cancer.
[4] Hongbin Wang,et al. Overexpression of LAPTM4B: an independent prognostic marker in breast cancer , 2013, Journal of Cancer Research and Clinical Oncology.
[5] Wei Jiang,et al. Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma. , 2012, American journal of surgery.
[6] A. Richardson,et al. The amplified cancer gene LAPTM4B promotes tumor growth and tolerance to stress through the induction of autophagy , 2012, Autophagy.
[7] Xiaoming Ning,et al. LAPTM4B Overexpression is a Novel Independent Prognostic Marker for Metastatic Ovarian Tumors , 2012, International Journal of Gynecologic Cancer.
[8] A. Richardson,et al. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells. , 2011, Cancer research.
[9] D. Rotin,et al. A Role for the Ubiquitin Ligase Nedd4 in Membrane Sorting of LAPTM4 Proteins , 2011, PloS one.
[10] F. Roviello,et al. Changing clinical and pathological features of gastric cancer over time , 2011, The British journal of surgery.
[11] Xia Li,et al. Over‐expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer , 2011, Journal of surgical oncology.
[12] J. Rui,et al. Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells. , 2011, Surgery.
[13] M. McNutt,et al. Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients , 2011, Surgery Today.
[14] Paolo Bechi,et al. Genomic and genetic alterations influence the progression of gastric cancer. , 2011, World journal of gastroenterology.
[15] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[16] H. Li,et al. LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling , 2010, Oncogene.
[17] M. McNutt,et al. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo. , 2010, Cancer letters.
[18] J. Ajani,et al. Gastric cancer--an enigmatic and heterogeneous disease. , 2010, JAMA.
[19] J. Rui,et al. LAPTM4B‐35 is a novel prognostic factor of hepatocellular carcinoma , 2010, Journal of surgical oncology.
[20] J. Coebergh,et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. , 2010, European journal of cancer.
[21] J. Rui,et al. Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro. , 2010, American journal of surgery.
[22] Ming-zhu Yin,et al. LAPTM4B-35 Overexpression Is an Independent Prognostic Marker in Endometrial Carcinoma , 2010, International Journal of Gynecologic Cancer.
[23] Zoltan Szallasi,et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer , 2010, Nature Medicine.
[24] R. Zhou,et al. LAPTM4B‐35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells , 2009, Cancer science.
[25] C. O'Morain,et al. Nature meets nurture: molecular genetics of gastric cancer , 2009, Human Genetics.
[26] M. Coleman,et al. Long-term survival expectations of cancer patients in Europe in 2000-2002. , 2009, European journal of cancer.
[27] J. Rui,et al. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma. , 2008, Cancer letters.
[28] J. Rui,et al. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma. , 2007, European journal of cancer.
[29] Y. Liu,et al. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] J. Rui,et al. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma. , 2005, World journal of gastroenterology.
[31] F. Bosman,et al. DNA-Ploidy in Advanced Gastric Carcinoma is Less Heterogeneous than in Early Gastric Cancer , 2004, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[32] J. Rui,et al. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma. , 2004, World journal of gastroenterology.
[33] Jun Liu,et al. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma , 2003, Oncogene.
[34] Jing He,et al. [Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells]. , 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.
[35] J. Rui,et al. [Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene]. , 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.
[36] Aller,et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.
[37] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[38] Michael R Hamblin,et al. CA : A Cancer Journal for Clinicians , 2011 .